Skip to main content
. 2019 Jun 12;106(1):57–59. doi: 10.1002/cpt.1476

Table 1.

Examples of RWD that would inform global health research and development for infectious disease

Data type Sources and current availability
Global Burden of Disease WHO, IHMEa (Lancet publications and on‐line); Academic centers of excellence through country‐specific alliances (e.g., LSHTM)
DALY estimates IHME (GBD project)
Population risk factors IHME, GHDx; CDC and equivalent country‐specific organizations
Force of infection Clinical trial data (disease networks, publications); Academic centers (e.g., Imperial College, Institute Pasteur); IDM
Longitudinal patient‐level data Clinical trial data (CPTR, TB, and malaria networks); EHR data (India only); Natural History Data (CDC and equivalents, foundationsa)

CDC, Centers for Disease Control; CPTR, Critical Path to TB Drug Regimens; DALY, disability‐adjusted life year; EHR, electronic health record; GBD, global burden of disease; GHDx, Global Health Data Exchange; IDM, Institute for Disease Modeling; IHME, Institute for Health Metric Evaluation; LSHTM, London School of Hygiene and Tropical Medicine; RWD, real‐world data; TB, tuberculosis; WHO, World Health Organization.

aFor example, KNCV Tuberculosis Foundation, The Hague, The Netherlands.